[1]
Mahsa Babaei et al. 2023. Redox-Sensitive Targeted Doxorubicin-Loaded Chitosan-based Nanoparticles to Treat Breast Cancer. Journal of Population Therapeutics and Clinical Pharmacology. 30, 4 (Mar. 2023), 267–282. DOI:https://doi.org/10.47750/jptcp.2023.30.04.026.